Lincoln Pharmaceuticals Limited — Board Meeting, 13-08-2026: Outcome of Board Meeting
13-08-2026 | 11:49 am
13-08-2026 | 11:49 am
Lincoln Pharma Q1 FY27 consolidated net profit jumped 30.90% YoY to ₹36.23 Cr, with total income up 19.02% to ₹201.55 Cr. Board proposed an 18% (₹1.80/share) dividend for FY26. Company targets ₹1000 Cr revenue in 3 years. #LincolnPharma #Earnings
No comments yet. Be the first to comment!
